These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 35675923)
1. End-point definition and trial design to advance tuberculosis vaccine development. Garcia-Basteiro AL; White RG; Tait D; Schmidt AC; Rangaka MX; Quaife M; Nemes E; Mogg R; Hill PC; Harris RC; Hanekom WA; Frick M; Fiore-Gartland A; Evans T; Dagnew AF; Churchyard G; Cobelens F; Behr MA; Hatherill M Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35675923 [TBL] [Abstract][Full Text] [Related]
2. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development. Hu Z; Lu SH; Lowrie DB; Fan XY Front Immunol; 2022; 13():895020. PubMed ID: 35812383 [TBL] [Abstract][Full Text] [Related]
3. Vaccine development against tuberculosis before and after Covid-19. Kaufmann SHE Front Immunol; 2023; 14():1273938. PubMed ID: 38035095 [TBL] [Abstract][Full Text] [Related]
4. [Latest advances in the development of tuberculosis vaccines in global clinical trials: a review]. Zhou F; Zhang Y; Zhang D Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):201-206. PubMed ID: 38857967 [TBL] [Abstract][Full Text] [Related]
9. Advances in development of new tuberculosis vaccines. da Costa C; Onyebujoh P; Thiry G; Zumla A Curr Opin Pulm Med; 2023 May; 29(3):143-148. PubMed ID: 36866744 [TBL] [Abstract][Full Text] [Related]
10. An Update on Tuberculosis Vaccines. Gopalaswamy R; Subbian S Methods Mol Biol; 2022; 2410():387-409. PubMed ID: 34914059 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. Development of tuberculosis vaccines in clinical trials: Current status. Méndez-Samperio P Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850 [TBL] [Abstract][Full Text] [Related]
15. Peptide-Based Vaccines for Tuberculosis. Gong W; Pan C; Cheng P; Wang J; Zhao G; Wu X Front Immunol; 2022; 13():830497. PubMed ID: 35173740 [TBL] [Abstract][Full Text] [Related]
17. Tuberculosis vaccines and prevention of infection. Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938 [TBL] [Abstract][Full Text] [Related]
18. Current status of new tuberculosis vaccine in children. Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369 [TBL] [Abstract][Full Text] [Related]
19. Human biomarkers: can they help us to develop a new tuberculosis vaccine? Fletcher HA; Dockrell HM Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133 [TBL] [Abstract][Full Text] [Related]